- Joined
- Sep 16, 2008
- Messages
- 3,010
- Reaction score
- 2,499
Riddle me this:
If someone is osteopenic, we give Calcium/Vitamin D supplementation. The vitamin D in caltrate is 400 U of D3, BID, so that's 5600 U of D3 per week. (that D3 is a calcitriol analog, right? read to go).
If we later find out same patient is 25-hydroxy deficient (the typical lab we check), does it then make sense to add ergocalciferol (a D2 analog), 50KU/week, on top of the D3 we're giving? Put another way, if you're already giving a D3 analog, why would you give a D2 analog that requires further hydroxylation to become active? Isn't that a little overkill, or is it necessary to make sure you have enough active D3?
If someone is osteopenic, we give Calcium/Vitamin D supplementation. The vitamin D in caltrate is 400 U of D3, BID, so that's 5600 U of D3 per week. (that D3 is a calcitriol analog, right? read to go).
If we later find out same patient is 25-hydroxy deficient (the typical lab we check), does it then make sense to add ergocalciferol (a D2 analog), 50KU/week, on top of the D3 we're giving? Put another way, if you're already giving a D3 analog, why would you give a D2 analog that requires further hydroxylation to become active? Isn't that a little overkill, or is it necessary to make sure you have enough active D3?